After some major hiccups last year, new breakthroughs suggest CRISPR is becoming a mainstay in healthcare. The technology is now…
McAlinden Research PartnersMay 28, 2019
“CRISPR babies” have been on everyone’s lips since news broke last week that Chinese scientists claimed they had produced the…
McAlinden Research PartnersDecember 4, 2018
CRISPR stocks have gotten battered in the second half of the year, yet the precision gene-editing technology is proving to…
McAlinden Research PartnersOctober 25, 2018
While the US meat industry has lately been racked by trade war fallout, resulting in huge surpluses, domestic demand is…
McAlinden Research PartnersAugust 9, 2018
Market reaction to a report that cells edited with CRISPR technology can activate a cancer-causing gene has been severe for…
McAlinden Research PartnersJune 13, 2018
